Trial Details
COMPLETEDBasic Information
| Clinical ID | c979 |
|---|---|
| Identifier | NCT00853099 |
| Trial Title | A Study of Adalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | BIOLOGICAL: adalimumab|DRUG: placebo |
Participant Information
| Sponsor | AbbVie (prior sponsor, Abbott) |
|---|---|
| City | Asahikawa |
| Country/Region | Japan |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-02-09 |
|---|---|
| Primary Completion Date | 2025-05-11 |
| Completion Date | 2025-08-13 |